RedShiftBio at Formulation and Delivery UK 2024
From April 25 -26, 2024, RedShiftBio will be among the 400+ leaders, experts, and researchers in the field of biopharma formulation and delivery at Oxford Global's Formulation & Delivery 2024. Connect with us for high-level discussions on how Microfluidic Modulation Spectroscopy (MMS) can elevate pharmaceutical drug formulation, by offering ultra-sensitive, and ultra-precise secondary structure measurements of proteins and other biomolecules. Learn why top biopharma trusts MMS to help ensure the stability and safety of their formulations with the ability to see small but significant structural changes that traditional spectroscopic methods miss.
Visit us! Our team will be onsite, at your service, at Booth 14.
Featured Presentation:
Track: BIOANALYSIS: STABILITY, CHARACTERIZATION, DEVELOPABILITY
Date/Time: April 25, 12:10 pm
Title: Microfluidic Modulation Spectroscopy(MMS): Highly-Sensitive and Automated IR-Based Structural Analysis. A Technology Overview with Peptide, Protein, and mRNA Examples
MMS is a revolution in IR spectroscopy, providing 30x greater sensitivity than traditional systems, using only a 50µl sample on a fully-automated platform, Aurora. This presentation describes the technology and provides examples of peptide, protein, RNA, and oligonucleotide experiments.
Speaker: Patrick King, PhD
POSTER PRESENTATION : Structural Characterization and Comparison of Temperature and Pressure Stress on a Protein Library Across pH and Concentration Using Microfluidic Modulation Spectroscopy
Presented by: Patrick King, PhD
